Category Added in a WPeMatico Campaign
If you’re a specialty pharmaceutical manufacturer preparing to launch a new therapy, establishing a patient program that supports the patient’s journey from end to end—from therapy initiation to positive health outcomes—is critical. So much so, it may be the difference between success and failure for the program, and for the therapeutic benefit of your brand. […]
Taking specialty medication is not usually as easy as taking a once daily pill. Rather, many specialty products require careful patient focus on how they should be handled and administered properly. Even when patients are prescribed a daily oral specialty medication, many of those oral medications come with a toxicity profile, or even a food requirement that must be carefully understood. For some specialty medications, patients may need to arrange travel and overnight stays if they’re receiving treatment administered at a location that might not be nearby. […]
Supporting patients throughout the entire specialty therapy journey is essential to achieving positive health outcomes. More and more, data is what lies at the heart of this critical objective. As CareMetx’s latest report, The Evolving Landscape of Digital Hubs revealed, the ability to integrate data seamlessly, then analyze and report on it effectively is critical for manufacturers that rely on digital hubs to support their drug programs. […]
When hub services providers like CareMetx think about how to support the entire patient journey on therapy, we recognize three key phases: initiation, adherence, and persistence. Each is critical to a patient’s success on therapy and their health outcomes. […]
CareMetx is committed to supporting the patient journey in a way that improves therapy adherence, persistence, and health outcomes. To inform this work, our team is always deeply interested in understanding what pharmaceutical manufacturers most need in a digital hub in order to achieve those objectives. So, we took a deep dive into this topic, conducting a comprehensive study involving one-on-one interviews and surveys with leading manufacturers. […]
To ensure patients can fully benefit from prescribed therapies, it’s critical to identify and address the barriers that impede their ability to access, afford, initiate, adhere to, and stay on treatment. The specialty treatment journey is a complex one, with many points along the way where these barriers can jeopardize the patient experience and health outcomes. […]
This client, the manufacturer of a self-injected rheumatology biologic, partnered with CareMetx to equip healthcare providers (HCPs) to support patients throughout their journey. CareMetx developed an omnichannel one-to-one patient and HCP support program, driven by a single platform, with touchpoints targeted to key points like first fill and first injection. […]
This leading pharmaceutical manufacturer contracted with CareMetx for an integrated patient support program to boost adherence and persistence for an oral oncology medication. CareMetx mapped the patient journey specific to this indication, then developed personalized touchpoints along the way, guided by a barrier assessment that identified the obstacles most likely to impact a given patient. […]
It’s a surprisingly common misconception that the patient experience relating to initiating specialty treatments is straightforward once a prescription has been ordered, and once approval has been received from the payer. The truth is, the hurdles patients must overcome to access and adhere to specialty medication are numerous and ongoing. […]
Over time, ongoing improvements in technology have allowed pharmaceutical brands to communicate with patients through a growing number of channels- apps, video chat, and patient portals to name a few. […]
Headquarters: 6931 Arlington Road, Suite 400 Bethesda, Maryland 20814
Copyright © 2022 CareMetx, LLC All Rights Reserved